AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29437202 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (primarily brisk walking)
Number of subjects: 95
Study 29437202 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 95
Study 29437202 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 95
Study 26930568 — intervention group
Group type: EXPERIMENTAL
Intervention: High spinal anesthesia
Number of subjects: 14
Study 26930568 — intervention group
Group type: COMPARATOR
Intervention: Control group (general anesthesia only)
Number of subjects: 14
Study 25203332 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketamine 0.5 mg/kg (Group K)
Number of subjects: 150
Study 25203332 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tramadol 0.5 mg/kg (Group T)
Number of subjects: 150
Study 25203332 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group P)
Number of subjects: 150
Study 25203332 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study 22753773 — intervention group
Group type: COMPARATOR
Intervention: Tocilizumab 8 mg/kg
Number of subjects: 489
Study 22753773 — intervention group
Group type: COMPARATOR
Intervention: Tocilizumab 4 mg/kg
Number of subjects: 489
Study 22753773 — intervention group
Group type: COMPARATOR
Intervention: Tocilizumab (both doses)
Number of subjects: 489
Study 20929380 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation intervention (90-minute session per week for 7 weeks)
Number of subjects: 31
Study 20929380 — intervention group
Group type: EXPERIMENTAL
Intervention: Education class based on Powerful Tools for Caregivers (90-minute session per week for 7 weeks)
Number of subjects: 31
Study 20929380 — intervention group
Group type: COMPARATOR
Intervention: Respite-only group (same duration of respite care as active interventions)
Number of subjects: 31
Study 20929380 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation intervention
Number of subjects: 31
Study 20929380 — intervention group
Group type: EXPERIMENTAL
Intervention: Education class based on Powerful Tools for Caregivers
Number of subjects: 31
Study 17662102 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (180 microg/week) for 60 wk
Number of subjects: 13
Study 17662102 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (180 microg/week) for 12 wk followed by 48 wk of peginterferon alfa-2a plus lamivudine
Number of subjects: 13
Study 15876830 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis
Number of subjects: 0
Study 15876830 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose hemodialysis
Number of subjects: 0
Study 15876830 — intervention group
Group type: COMPARATOR
Intervention: Conventional three times per week hemodialysis
Number of subjects: 0
Study 12037147 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous ultralente insulin, administered twice daily for a total dose of 0.25 unit per kilogram of body weight per day, plus annual four-day continuous intravenous infusions of insulin.
Number of subjects: 339
Study 12037147 — intervention group
Group type: COMPARATOR
Intervention: Close observation (Control group)
Number of subjects: 339
Study 12037147 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous ultralente insulin
Number of subjects: 339
Study 10215708 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% ropivacaine with hyaluronidase
Number of subjects: 100
Study 10215708 — intervention group
Group type: COMPARATOR
Intervention: 0.75% bupivacaine with hyaluronidase
Number of subjects: 100
Study 7890058 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms SC GRF on cycle days 2 to 11
Number of subjects: 7
Study 7890058 — intervention group
Group type: COMPARATOR
Intervention: Control cycle (no treatment)
Number of subjects: 7
Study 2213040 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 60
Study 444954 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-drug regimen (vinblastine and procarbazine)
Number of subjects: 108
Study 444954 — intervention group
Group type: COMPARATOR
Intervention: Four-drug regimen (MVPP)
Number of subjects: 108
Study 29577789 — intervention group
Group type: EXPERIMENTAL
Intervention: Double transverse compression suture at the lower uterine segment plus intrauterine inflated Foley's catheter Balloon (H&N variation sandwich)
Number of subjects: 106
Study 29577789 — intervention group
Group type: COMPARATOR
Intervention: Stepwise uterine devascularization
Number of subjects: 106
Study 28283694 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic anchors
Number of subjects: 28
Study 28283694 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid railing
Number of subjects: 28
Study 28283694 — intervention group
Group type: COMPARATOR
Intervention: Both haptic tools (rigid railing and haptic anchors)
Number of subjects: 28
Study 26188373 — intervention group
Group type: EXPERIMENTAL
Intervention: PST with weekly support (n = 106)
Number of subjects: 537
Study 26188373 — intervention group
Group type: COMPARATOR
Intervention: PST without support (n = 107)
Number of subjects: 537
Study 26188373 — intervention group
Group type: COMPARATOR
Intervention: PST with support on request (n = 108)
Number of subjects: 537
Study 26188373 — intervention group
Group type: COMPARATOR
Intervention: No Internet‐based intervention but non‐specific chat or email (n = 110)
Number of subjects: 537
Study 26188373 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC; n = 106)
Number of subjects: 537
Study 23485413 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (1200 IU/d)
Number of subjects: 114
Study 23485413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 20932687 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (CRT)
Number of subjects: 207
Study 20932687 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiotherapy (RT)
Number of subjects: 207
Study 19154656 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Placebo
Number of subjects: 18
Study 19154656 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Ketamine (0.3 mg/kg i.v.)
Number of subjects: 18
Study 19154656 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg)/Ketamine (0.3 mg/kg i.v.)
Number of subjects: 18
Study 18589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin zeta (10,000 IU, intravenous bolus injection)
Number of subjects: 24
Study 18589555 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa (10,000 IU, intravenous bolus injection)
Number of subjects: 24
Study 15760929 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg IM depomedrone
Number of subjects: 91
Study 15760929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 12082319 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60
Study 12082319 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 60
Study 9498533 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous aspirin
Number of subjects: 19
Study 7624302 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 81
Study 7624302 — intervention group
Group type: COMPARATOR
Intervention: Abdominal ultrasonography (AUS)
Number of subjects: 81
Study 7624302 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 81
Study 7624302 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 81
Study 2620809 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability-learning task
Number of subjects: 200
Study 2620809 — intervention group
Group type: EXPERIMENTAL
Intervention: Piagetian tasks
Number of subjects: 200
Study 788529 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (varied doses)
Number of subjects: 8
Study 31519466 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-informed healthy eating blog (1 post per week for 6 months)
Number of subjects: 84
Study 29333665 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA)
Number of subjects: 200
Study 29333665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 28911085 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 540
Study 28911085 — intervention group
Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 540
Study 26466021 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated stent (umirolimus-coated)
Number of subjects: 2466
Study 26466021 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent
Number of subjects: 2466
Study 23122684 — intervention group
Group type: EXPERIMENTAL
Intervention: CIDR‐4 treatment (controlled internal drug release)
Number of subjects: 3822
Study 23122684 — intervention group
Group type: EXPERIMENTAL
Intervention: eCG (200 IU eCG im)
Number of subjects: 3822
Study 23122684 — intervention group
Group type: EXPERIMENTAL
Intervention: eCG+ECP (200 IU im eCG plus 0.5 mg ECP im)
Number of subjects: 3822
Study 23122684 — intervention group
Group type: EXPERIMENTAL
Intervention: eCG and eCG+ECP
Number of subjects: 3822
Study 23122684 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 3822
Study 23122684 — intervention group
Group type: EXPERIMENTAL
Intervention: ECP (0.5 mg)
Number of subjects: 3822
Study 21418145 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 71
Study 18006510 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse stroke care manager maintaining contact through home visits and telephone calls for 6 weeks post-discharge
Number of subjects: 190
Study 18006510 — intervention group
Group type: COMPARATOR
Intervention: Usual post-hospital care
Number of subjects: 190
Study 16339823 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetraethylammonium chloride (TEA; 9 micromol/min)
Number of subjects: 8
Study 16339823 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min) + fluconazole (0.4 micromol/min)
Number of subjects: 8
Study 16339823 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min) + tetraethylammonium chloride (TEA; 9 micromol/min)
Number of subjects: 8
Study 16339823 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (0.4 micromol/min)
Number of subjects: 8
Study 16339823 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min)
Number of subjects: 8
Study 16339823 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 8
Study 12972844 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative Treatment Planning (NTP) program
Number of subjects: 2222
Study 12972844 — intervention group
Group type: EXPERIMENTAL
Intervention: Client Feedback System (CFS) program
Number of subjects: 2222
Study 12972844 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NTP and CFS programs
Number of subjects: 2222
Study 12972844 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2222
Study 11069453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (liquid nitrogen spray, two freeze-thaw cycles, each freeze for 5-10 seconds)
Number of subjects: 67
Study 11069453 — intervention group
Group type: COMPARATOR
Intervention: Curettage and cautery (C&C)
Number of subjects: 67
Study 11069453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (lower leg lesions)
Number of subjects: 67
Study 11069453 — intervention group
Group type: COMPARATOR
Intervention: Curettage and cautery (C&C) (lower leg lesions)
Number of subjects: 67
Study 11069453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 67
Study 8642957 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual cleansing of the birth canal with a cotton pad soaked in 0.25% chlorhexidine, done on admission in labour and every 4 h until delivery.
Number of subjects: 6964
Study 8642957 — intervention group
Group type: COMPARATOR
Intervention: Conventional delivery procedures (control group).
Number of subjects: 6964
Study 8642957 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual cleansing of the birth canal with a cotton pad soaked in 0.25% chlorhexidine.
Number of subjects: 6964
Study 1499461 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg miglitol
Number of subjects: 36
Study 1499461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 1499461 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 36
Study 6360055 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine in cardioplegic solution
Number of subjects: 205
Study 6360055 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nifedipine)
Number of subjects: 205
Study 31843180 — intervention group
Group type: EXPERIMENTAL
Intervention: Short dental implants
Number of subjects: 0
Study 31843180 — intervention group
Group type: COMPARATOR
Intervention: Maxillary sinus augmentation with longer implants
Number of subjects: 0
Study 30638392 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 100
Study 30638392 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 26873402 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased activation in the left prefrontal and right parietal regions during acute phase II
Number of subjects: 34
Study 26873402 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength of functional connectivity between the right parietal and left prefrontal and parietal regions
Number of subjects: 34
Study 26873402 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger activation of left functional homologues
Number of subjects: 34
Study 26873402 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial functional connectivity between contralesional functional homologues
Number of subjects: 34
Study 24393220 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-located acute/rehabilitation stroke care
Number of subjects: 41
Study 24393220 — intervention group
Group type: COMPARATOR
Intervention: Traditionally separated acute/rehabilitation stroke care
Number of subjects: 41
Study 21362055 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) session (75 Hz, 40 contractions, 6.25 s per contraction)
Number of subjects: 13
Study 20714969 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion and ToM Imitation Training (ETIT)
Number of subjects: 16
Study 20714969 — intervention group
Group type: COMPARATOR
Intervention: Problem Solving Training (Control)
Number of subjects: 16
Study 18625352 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A-1 (540 mg I/kg body weight, imaging delay 15s)
Number of subjects: 80
Study 18625352 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A-2 (540 mg I/kg body weight, imaging delay 18s)
Number of subjects: 80
Study 18625352 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A-3 (540 mg I/kg body weight, imaging delay 21s)
Number of subjects: 80
Study 18625352 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (720 mg I/kg body weight, imaging delay 18s)
Number of subjects: 80
Study 15854431 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone (SM/FP) 50/100 microg twice daily via Accuhaler
Number of subjects: 398
Study 15854431 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (BUD) 400 microg twice daily via Turbuhaler
Number of subjects: 398
Study 15854431 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone (SM/FP)
Number of subjects: 398
Study 15854431 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (BUD)
Number of subjects: 398
Study 11916904 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose infusion (1.2 mg.kg(‐1).min(‐1))
Number of subjects: 7
Study 10398352 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale (GDS15)
Number of subjects: 257
Study 7586765 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (1.5-2.0 mg/h i.v.)
Number of subjects: 46
Study 7586765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 1971504 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 4.5 million U/d with zidovudine 200 mg every 4 hours
Number of subjects: 43
Study 1971504 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 18 million U/d with zidovudine 100 mg every 4 hours
Number of subjects: 43
Study 1971504 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 9 million U/d with zidovudine 100 or 200 mg every 4 hours
Number of subjects: 43
Study 1971504 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CD4 counts above 200 x 10(6) cells/L
Number of subjects: 43
Study 1971504 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CD4 counts below 200 x 10(6) cells/L
Number of subjects: 43
Study 1971504 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with interferon-alpha and zidovudine
Number of subjects: 43
Study 7333851 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed material
Number of subjects: 400
Study 7333851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse telephone calls
Number of subjects: 400
Study 7333851 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 400
Study 7333851 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 400
Study 31411632 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of CPR adjunct device
Number of subjects: 3643
Study 31411632 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal CCR-CCD combination of 107 compressions per minute and a depth of 4.7 cm
Number of subjects: 3643
Study 31411632 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 3643
Study 30002395 — intervention group
Group type: EXPERIMENTAL
Intervention: REBEL RELIEVER unloading knee brace + usual care (Brace group, N=32)
Number of subjects: 67
Study 30002395 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (Control group, N=35)
Number of subjects: 67
Study 27982672 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-integrated patient-reported outcomes (PROs) during the PRO phase
Number of subjects: 0
Study 27982672 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study 27982672 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-integrated patient-reported outcomes (PROs) during the education phase
Number of subjects: 0
Study 27982672 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider satisfaction in intervention group
Number of subjects: 0
Study 27982672 — intervention group
Group type: COMPARATOR
Intervention: Provider satisfaction in control group
Number of subjects: 0
Study 24618069 — intervention group
Group type: EXPERIMENTAL
Intervention: DES ODF (2.0 mg)
Number of subjects: 12
Study 24618069 — intervention group
Group type: COMPARATOR
Intervention: DES-capsule (2.0 mg)
Number of subjects: 12
Study 24618069 — intervention group
Group type: EXPERIMENTAL
Intervention: DES ODF
Number of subjects: 12
Study 22545363 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydro alcoholic nettle extract (100 mg kg(‐1) for 8 weeks)
Number of subjects: 50
Study 22545363 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 20051451 — intervention group
Group type: EXPERIMENTAL
Intervention: Steri-Strip S
Number of subjects: 81
Study 20051451 — intervention group
Group type: COMPARATOR
Intervention: Intracuticular suture
Number of subjects: 81
Study 17675057 — intervention group
Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 206
Study 17675057 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 206
Study 15730578 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Decompression (SD)
Number of subjects: 152
Study 15730578 — intervention group
Group type: COMPARATOR
Intervention: Anterior Subcutaneous Transposition (AST)
Number of subjects: 152
Study 12549796 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure controlled mode
Number of subjects: 12
Study 12549796 — intervention group
Group type: COMPARATOR
Intervention: Volume controlled mode
Number of subjects: 12
Study 9797905 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic training twice a week for 10 weeks
Number of subjects: 53
Study 8559437 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin 3.2 mg given as a depot every 28 days for 6 months
Number of subjects: 43
Study 8559437 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA) 10 mg from day 16 to day 25 of each month for 6 months
Number of subjects: 43
Study 2558701 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (100 micrograms - 4000 micrograms)
Number of subjects: 7
Study 2558701 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 7
Study 2558701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2558701 — intervention group
Group type: COMPARATOR
Intervention: Inhaled salbutamol (identical dose protocol) in young subjects (24 +/- 3 years)
Number of subjects: 7
Study 64807 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 104
Study 64807 — intervention group
Group type: COMPARATOR
Intervention: Calcium gluconate
Number of subjects: 104
Study 64807 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbitone
Number of subjects: 104
Study 31309235 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) supplementation
Number of subjects: 152
Study 31309235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 28961171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mango flesh
Number of subjects: 12
Study 28961171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mango juice
Number of subjects: 12
Study 26457099 — intervention group
Group type: EXPERIMENTAL
Intervention: Olea ointment
Number of subjects: 30
Study 26457099 — intervention group
Group type: COMPARATOR
Intervention: Acetate Mafenide ointment (8.5%)
Number of subjects: 30
Study 23815885 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetric nurse or professional midwife
Number of subjects: 2254